These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 24265365)
1. Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. Porcellati F; Lucidi P; Bolli GB; Fanelli CG Diabetes Care; 2013 Dec; 36(12):3860-2. PubMed ID: 24265365 [No Abstract] [Full Text] [Related]
2. Comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062. Carr RD; Alexander CM Diabetes Care; 2014 Jul; 37(7):e161-2. PubMed ID: 24963116 [No Abstract] [Full Text] [Related]
3. Response to comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062. Monnier L; Colette C; Dejager S; Owens D Diabetes Care; 2014 Jul; 37(7):e163. PubMed ID: 24963117 [No Abstract] [Full Text] [Related]
4. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Monnier L; Colette C; Dejager S; Owens D Diabetes Care; 2013 Dec; 36(12):4057-62. PubMed ID: 24170753 [TBL] [Abstract][Full Text] [Related]
6. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy. Mukherjee JJ; Majumdar S; Ray S J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486 [No Abstract] [Full Text] [Related]
8. [New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines]. Adler AI; Shaw EJ; Stokes T; Ruiz F Praxis (Bern 1994); 2009 Oct; 98(20):1161-3. PubMed ID: 19809980 [No Abstract] [Full Text] [Related]
9. HbA(1c) and glycemic profile, basal- and post-treatment with Miglitol, in an area with a Mediterranean diet. Faure E; Pallardo LF; Mesa J; Puig-Domingo M; García-Mayor R; Benito P; Ravella R; Artés M; López JS; Diabetes Care; 2002 Oct; 25(10):1896-8. PubMed ID: 12351510 [No Abstract] [Full Text] [Related]
13. Prospective EHR-based clinical trials: the challenge of missing data. Kharrazi H; Wang C; Scharfstein D J Gen Intern Med; 2014 Jul; 29(7):976-8. PubMed ID: 24839057 [No Abstract] [Full Text] [Related]
14. New insights into the older hypoglycemic agents in type 2 diabetes therapy. Cao M; Bloomgarden Z J Diabetes; 2020 Nov; 12(11):844-847. PubMed ID: 32767624 [No Abstract] [Full Text] [Related]